EE10 Cost-Effectiveness of Tenofovir/Lamivudine/Efavirenz Versus Tenofovir/Lamivudine/Dolutegravir for Preventing Mother-to-Child Transmission of HIV in Nigeria
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.262
https://www.valueinhealthjournal.com/article/S1098-3015(22)00463-6/fulltext
Title :
EE10 Cost-Effectiveness of Tenofovir/Lamivudine/Efavirenz Versus Tenofovir/Lamivudine/Dolutegravir for Preventing Mother-to-Child Transmission of HIV in Nigeria
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00463-6&doi=10.1016/j.jval.2022.04.262
First page :
Section Title :
Open access? :
No
Section Order :
10226